These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3249552)

  • 1. Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.
    Musset M; Mathé G; Reizenstein P
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():17-20. PubMed ID: 3249552
    [No Abstract]   [Full Text] [Related]  

  • 2. Serum lipid-bound sialic acid as a tumoral marker in minimal residual tumors.
    Musset M; Mathé G; Reizenstein P
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):17-20. PubMed ID: 2663215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum sialic acid (TSA/LSA) and carcinoembryonic antigen (CEA) levels in cancer patients undergoing radiotherapy.
    Stringou E; Chondros K; Kouvaris J; Kakari S; Papavassiliou K
    Anticancer Res; 1992; 12(1):251-5. PubMed ID: 1567173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The significance of neopterin determination as a tumour marker in ovarian cancer.
    Szarka G; Pulay T; Csömör S; Tran-Phoung-Mai ; Schumann B
    Acta Chir Hung; 1988; 29(4):359-64. PubMed ID: 3239335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The importance of polyamine determination in monitoring malignant gynaecological tumours.
    Szarka G; Pulay T; Csömör S; Tran-Phuong-Mai ; Schumann B
    Acta Chir Hung; 1988; 29(4):365-72. PubMed ID: 3239336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new marker in oncology. Assay of gangliosides bound to sialic acid].
    Pignat JC; Portoukalian M; Poupart M; Haguenauer JP; Richard M
    Ann Otolaryngol Chir Cervicofac; 1989; 106(8):547-9. PubMed ID: 2619157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A simple method of measuring serum sialic acid level as a neoplasm marker].
    Tadeusiak W; Sadłowska B; Krawczyński MJ
    Pol Tyg Lek; 1987 Jul 6-7; 42(27-28):845-8. PubMed ID: 3684762
    [No Abstract]   [Full Text] [Related]  

  • 8. Lipid-bound sialic acid as a tumor marker.
    Dnistrian AM; Schwartz MK
    Ann Clin Lab Sci; 1983; 13(2):137-42. PubMed ID: 6859805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Usefulness of sialic acid as a tumor marker].
    Feliú J; Daimiel E; Vicente J; Martín G; García Girón C; Chacón I; González Barón M
    Rev Clin Esp; 1989 May; 184(8):401-3. PubMed ID: 2781072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring and treatment of minimal residual cancer of the prostate.
    Mathé G; Schally AV; Comaru-Schally AM; Mauvernay RY; Vovan ML; Machover D; Misset JL; Court B; Bouchard P; Duchier J
    Suppl J Med Oncol Tumor Pharmacother; 1988; 1():65-74. PubMed ID: 3074228
    [No Abstract]   [Full Text] [Related]  

  • 11. [Serum lipid-associated sialic acid (LSA) in diagnosing and monitoring ovarian cancer].
    Yue K; Bian M; Zhu D; Liu W; Siu S
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1995 Apr; 17(2):128-32. PubMed ID: 7656393
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sialic acid--an acute phase reactant and a concomitant of tumors].
    Simmich T; Dehne A; Laube K; Laube N; Frank KH
    Z Med Lab Diagn; 1991; 32(3-4):188-92. PubMed ID: 1897297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total and lipid-bound serum sialic acid in children with malignancy or infections.
    Romppanen J; Petäjä J; Heikinheimo M; Mononen I
    Anticancer Res; 1998; 18(4B):2793-7. PubMed ID: 9713463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of lipid-associated sialic acid (LSA) and prostate specific antigen (PSA) in the follow-up of prostatic cancer.
    Meyer U; Dierig C; Katopodis N; De Bruijn CH
    Anticancer Res; 1993; 13(5C):1889-94. PubMed ID: 7505544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between serum levels of carcinoembryonic antigen, sialic acid and phosphohexose isomerase in lung cancer.
    Patel PS; Raval GN; Rawal RM; Patel GH; Balar DB; Shah PM; Patel DD
    Neoplasma; 1995; 42(5):271-4. PubMed ID: 8552208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of ferritin, lipid-associated sialic acid, CEA, squamous cell carcinoma (SCC) antigen, and CYFRA 21-1 levels in SCC of the head and neck.
    Inal E; Laçin M; Asal K; Ceylan A; Köybaşioğlu A; Ileri F; Uslu SS
    Kulak Burun Bogaz Ihtis Derg; 2004; 12(1-2):23-30. PubMed ID: 16010093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined measurement and significance of lipid-bound sialic acid and carcinoembryonic antigen in detection of human cancer.
    Munjal DD; Picken J; Pritchard J
    Diagn Immunol; 1984; 2(1):36-43. PubMed ID: 6499373
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Circulating lipid-bound sialic acid levels in patients with malignant tumors].
    Bassalyk LS; Novikov AM; Sokolova VD; Sorokin EN
    Vopr Med Khim; 1984; 30(3):124-7. PubMed ID: 6474937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring and treatment of minimal residual cancer of the prostate.
    Mathé G; Schally AV; Comaru-Schally AM; Mauvernay RY; Vovan ML; Machover D; Misset JL; Court B; Bouchard P; Duchier J
    Bull Soc Sci Med Grand Duche Luxemb; 1989; 126(1):65-74. PubMed ID: 2525968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sialic acid in the serum--an indicator for malignant growth?].
    Schulze G
    Arch Geschwulstforsch; 1990; 60(1):19-24. PubMed ID: 2310297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.